Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Duchemann

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|August 12, 2022
Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18-18 and EGFR amplification: A case reportPascal Wang, Emmanuelle Fabre, Antoine Martin, et al.
British Journal of Cancer|June 4, 2024
Why does circadian timing of administration matter for immune checkpoint inhibitors' efficacy?Abdoulaye Karaboué, Pasquale F Innominato, Nicholas I Wreglesworth, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|May 10, 2021
Endobronchial Seeding of Squamous Lung Carcinoma with Mediastinal Lymph Involvement Node after EBUS: A Case ReportBoris Duchemann, Ana Maria Portela, Pascal Joudiou, et al.
Breathe (Sheffield, England)|November 13, 2024
The CheckMate 816 trial: a milestone in neoadjuvant chemoimmunotherapy of nonsmall cell lung cancerMarie Mayenga, Ana Rita Pedroso, Marion Ferreira, et al.
Bulletin Du Cancer|October 14, 2022
[Postoperative radiotherapy in non-small cell lung cancer stage IIIA - N2: Focus and perspectives]Pascal Wang, Boris Duchemann, Kader Chouahnia, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 2, 2013
Epidemiology of idiopathic pulmonary fibrosis in Europe--an updateI Annesi-Maesano, Hilario Nunes, Boris Duchemann, et al.
Presse Medicale (Paris, France : 1983)|May 22, 2020
Adult interstitial lung diseases and their epidemiologyLucile Sesé, Warda Khamis, Florence Jeny, et al.
Clinics in Chest Medicine|November 24, 2015
Pulmonary SarcoidosisDominique Valeyre, Jean-François Bernaudin, Florence Jeny, et al.
Cancer Immunology, Immunotherapy : CII|August 11, 2021
Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trialsThierry Landre, Gregoire Justeau, Jean-Baptiste Assié, et al.
Bulletin Du Cancer|June 18, 2023
[Diagnosis and management of interstitial lung disease induced by antibody-drug conjugates in breast cancer: A French expert opinion paper]Luis Teixeira, Véronique Diéras, Bruno Crestani, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|August 12, 2022
Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18-18 and EGFR amplification: A case reportPascal Wang, Emmanuelle Fabre, Antoine Martin, et al.
British Journal of Cancer|June 4, 2024
Why does circadian timing of administration matter for immune checkpoint inhibitors' efficacy?Abdoulaye Karaboué, Pasquale F Innominato, Nicholas I Wreglesworth, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|May 10, 2021
Endobronchial Seeding of Squamous Lung Carcinoma with Mediastinal Lymph Involvement Node after EBUS: A Case ReportBoris Duchemann, Ana Maria Portela, Pascal Joudiou, et al.
Breathe (Sheffield, England)|November 13, 2024
The CheckMate 816 trial: a milestone in neoadjuvant chemoimmunotherapy of nonsmall cell lung cancerMarie Mayenga, Ana Rita Pedroso, Marion Ferreira, et al.
Bulletin Du Cancer|October 14, 2022
[Postoperative radiotherapy in non-small cell lung cancer stage IIIA - N2: Focus and perspectives]Pascal Wang, Boris Duchemann, Kader Chouahnia, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|October 2, 2013
Epidemiology of idiopathic pulmonary fibrosis in Europe--an updateI Annesi-Maesano, Hilario Nunes, Boris Duchemann, et al.
Presse Medicale (Paris, France : 1983)|May 22, 2020
Adult interstitial lung diseases and their epidemiologyLucile Sesé, Warda Khamis, Florence Jeny, et al.
Clinics in Chest Medicine|November 24, 2015
Pulmonary SarcoidosisDominique Valeyre, Jean-François Bernaudin, Florence Jeny, et al.
Cancer Immunology, Immunotherapy : CII|August 11, 2021
Anti-PD-(L)1 for KRAS-mutant advanced non-small-cell lung cancers: a meta-analysis of randomized-controlled trialsThierry Landre, Gregoire Justeau, Jean-Baptiste Assié, et al.
Bulletin Du Cancer|June 18, 2023
[Diagnosis and management of interstitial lung disease induced by antibody-drug conjugates in breast cancer: A French expert opinion paper]Luis Teixeira, Véronique Diéras, Bruno Crestani, et al.
Pageof 9